Itron Shares Plunge Despite Strong Quarterly Performance

Itron experienced a dramatic sell-off in after-hours trading yesterday, with its stock price collapsing by over 13%. This sharp decline occurred even as the company reported quarterly earnings that surpassed analyst expectations. The market’s negative reaction was primarily driven by disappointing revenue guidance and a subsequent analyst downgrade issued this morning.

Market Punishes Conservative Outlook

The technology company delivered an adjusted earnings per share of $1.54, exceeding the projected $1.48. Revenue reached $582 million, also beating estimates, though this figure represents a 5% decrease compared to the same period last year.

Despite these results, investor sentiment turned sharply negative, pushing shares down as much as 14.9% to $117.59. The sell-off was triggered by several factors:
* A modest downward revision to full-year revenue guidance, now projected between $2.35-2.36 billion
* Cautious fourth-quarter revenue expectations of $555-565 million
* Ongoing delays in project implementation timelines

Operational Strengths Overshadowed by Downgrade

Adding pressure to the stock, financial services firm Baird downgraded Itron from “Outperform” to “Neutral” this morning. The analyst simultaneously slashed its price target from $137 to $118 per share.

Should investors sell immediately? Or is it worth buying Itron?

This downgrade came despite several strong operational achievements:
* Gross margins reached an all-time high of 37.7%
* The company generated $113 million in free cash flow
* The order backlog remains substantial at $4.3 billion

Recovery Prospects Hinge on Revenue Growth

The divergence between robust profitability metrics and sluggish revenue growth continues to concern market participants. While management raised its 2025 earnings guidance to $6.84-6.94 per share, the revenue trajectory remains a significant vulnerability.

With the stock currently trading around $108.99, it approaches its 52-week low of $90.11. Upcoming investor conferences in November will provide management with crucial opportunities to address market concerns and potentially restore confidence in the company’s growth narrative.